Werbung
Werbung

PTGX

PTGX logo

Protagonist Therapeutics, Inc

138.64
USD
Gesponsert
+5.64
+4.24%
30. Juli, 15:59 UTC -4
Geschlossen
exchange

Vor-Markt

138.64

0.00
0.00%

Protagonist Therapeutics, Inc Finanzieller Schnappschuss

Markt Cap
8.92B
Beta
2.12
Gewinn pro Aktie (EPS)
-2.05
Kurs-Buchwert-Verhältnis (P/B)
10.59
Operative Marge
-282.83%
Gesamtverschuldung/Eigenkapital (D/E)
0.00%
Kurs-Gewinn-Verhältnis
--
Eigenkapitalrendite (ROE)
-19.89%
Aktuelles Verhältnis
12.71%
Freier Cash Flow
56.08M
PTGX Profil

Ertragsdiagramm

PTGXVerdienste

Aktuelle Nachrichten und Prognosen

Alle anzeigen

Aktien im Trend

Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1,279.96
+25.99%
Micron Technology, Inc. logo
Micron Technology, Inc.$874.66
+18.36%
Madrigal Pharmaceuticals, Inc. Common Stock logo
Madrigal Pharmaceuticals, Inc. Common Stock$493.11
-9.83%
Tradeweb Markets Inc. Class A Common Stock logo
Tradeweb Markets Inc. Class A Common Stock$97.80
-9.60%
S
SK hynix Inc. - ADR$149.00
+17.52%
Houlihan Lokey, Inc. logo
Houlihan Lokey, Inc.$128.34
-7.72%
The Sherwin-Williams Company logo
The Sherwin-Williams Company$344.84
+0.28%
Werbung